The interview isn't meant to discuss molecular bioavailability and comparative amyloid plaque removal efficacy rates. It was meant to allow a caregiver to share her personal story regarding a loved one who was suffering from the disease and was helped by the treatment. It did so in a moving way.
If you want to understand the biochemistry of it, search medical journals. There are more than a few examples. Here is a good one, specifically addressing amyloid plaque reduction by THC:
A Molecular Link between the Active Component of Marijuana and Alzheimer's Disease Pathology
Hey, @olyup! THANKS for understanding the pure motive behind this video, and also for sharing that helpful link. I value your contribution! 🌿
Thank you! The Salk Institute has an article on the same topic aimed at more general audience: https://www.salk.edu/news-release/cannabinoids-remove-plaque-forming-alzheimers-proteins-from-brain-cells/
Reading the actual research paper is probably a little dry for most people!
Excellent resource, @olyup! Thanks very much for strengthening this post by adding it. 😊